Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Natera, Inc. - Common Stock
(NQ:
NTRA
)
264.54
+2.55 (+0.97%)
Streaming Delayed Price
Updated: 9:54 AM EDT, Jul 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Natera, Inc. - Common Stock
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
Natera to Participate in Upcoming Investor Conferences
September 01, 2023
From
Natera, Inc.
Via
Business Wire
Natera’s Prospera™ Lung Transplant Assessment Test Granted Medicare Coverage
August 16, 2023
From
Natera, Inc.
Via
Business Wire
The Latest Analyst Ratings for Natera
↗
August 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
August 04, 2023
Via
Benzinga
Why Natera Stock Is Soaring Today
↗
August 04, 2023
This DNA testing leader passed the test in Q2.
Via
The Motley Fool
Earnings Scheduled For August 3, 2023
↗
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Natera Earnings Preview
↗
August 02, 2023
Via
Benzinga
What 7 Analyst Ratings Have To Say About Natera
↗
July 21, 2023
Via
Benzinga
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
August 04, 2023
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.
Via
Benzinga
Investors Cheer Jobs Report: Why Are These 5 Stocks And 5 ETFs Shining On Friday?
↗
August 04, 2023
Via
Benzinga
Analyst Expectations for Natera's Future
↗
May 30, 2023
Via
Benzinga
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
↗
August 04, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
August 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
August 03, 2023
Via
Benzinga
Natera Reports Second Quarter 2023 Financial Results
August 03, 2023
From
Natera, Inc.
Via
Business Wire
Natera to Participate in Canaccord Genuity 43rd Annual Growth Conference
August 02, 2023
From
Natera, Inc.
Via
Business Wire
Natera Files Patent Infringement Suit Against NeoGenomics
July 31, 2023
From
Natera, Inc.
Via
Business Wire
Natera Announces Completion of Enrollment to the Randomized, Phase III ALTAIR Trial of Signatera™ in Colorectal Cancer
July 28, 2023
From
Natera, Inc.
Via
Business Wire
Natera to Report its Second Quarter 2023 Results on August 3rd
July 27, 2023
From
Natera, Inc.
Via
Business Wire
Court Issues Favorable Ruling for Natera in False Advertising Trial Against CareDx; Eliminates all Damages
July 17, 2023
From
Natera, Inc.
Via
Business Wire
Natera to Participate in Goldman Sachs 44th Annual Global Healthcare Conference
June 06, 2023
From
Natera, Inc.
Via
Business Wire
Natera Announces Data from the ProActive Study that Supports Prospera™ Kidney as an Early Indicator of Transplant Rejection
June 04, 2023
From
Natera, Inc.
Via
Business Wire
New Natera Data to be Presented at the 2023 ASCO Annual Meeting in 13 Studies Across Multiple Cancer Types
May 30, 2023
From
Natera, Inc.
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
↗
May 26, 2023
Via
Benzinga
Jury Rules in Favor of Natera, Finding all Asserted Patents Valid and Infringed by ArcherDX/Invitae; Awards $19.35 Million in Past Damages for Royalties and Lost Profits
May 15, 2023
From
Natera, Inc.
Via
Business Wire
Natera Reports First Quarter 2023 Financial Results
May 09, 2023
From
Natera, Inc.
Via
Business Wire
Natera Announces New Publication from I-SPY2 Trial Reinforcing Clinical Utility of Signatera™ for Breast Cancer Patients in the Neoadjuvant Setting
May 08, 2023
From
Natera, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2023
↗
May 05, 2023
Via
Benzinga
Natera Announces First Quarter 2023 Earnings Conference Call
May 02, 2023
From
Natera, Inc.
Via
Business Wire
Natera Announces New Signatera™ MRD Data at 2023 AACR Annual Meeting
April 14, 2023
From
Natera, Inc.
Via
Business Wire
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
